MeiraGTx to Participate in Upcoming Investor Conferences

Rhea-AI Summary

MeiraGTx Holdings plc (MGTX) announced the participation of its President and CEO, Dr. Alexandria Forbes, in two upcoming investor conferences. The live webcasts of the corporate presentations will be available on the Investors page of the company’s website, with replays accessible for approximately 30 days following the presentation dates.

LONDON and NEW YORK, Nov. 21, 2023 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced that Alexandria Forbes, Ph.D., President and Chief Executive Officer, will participate in the following investor conferences:

• 6th Annual Evercore ISI HealthCONx Conference
  

Corporate presentation: Tuesday, November 28, 2023, at 10:25 a.m. ET

•  Piper Sandler 35th Annual Healthcare Conference
  

Corporate presentation: Thursday, November 30, 2023, at 9:00 a.m. ET

A live webcast of the corporate presentations will be available on the Investors page of the Company’s website at www.investors.meiragtx.com. Replays will be available for approximately 30 days following the presentation dates.

About MeiraGTx
MeiraGTx (Nasdaq: MGTX) is a vertically integrated, clinical-stage gene therapy company with six programs in clinical development and a broad pipeline of preclinical and research programs. MeiraGTx has core capabilities in viral vector design and optimization and gene therapy manufacturing, and a transformative gene regulation platform technology that allows precise, dose-responsive control of gene expression by oral small molecules with dynamic range that can exceed 5000-fold. Led by an experienced management team, MeiraGTx has taken a portfolio approach by licensing, acquiring, and developing technologies that give depth across both product candidates and indications. MeiraGTx’s initial focus is on three distinct areas of unmet medical need: ocular diseases, including both inherited retinal diseases as well as large degenerative ocular diseases, neurodegenerative diseases, and severe forms of xerostomia. Though initially focusing on the eye, central nervous system, and salivary gland, MeiraGTx plans to expand its focus to develop additional gene therapy treatments for patients suffering from a range of serious diseases.

For more information, please visit www.meiragtx.com

Contacts

Investors:
MeiraGTx
Investors@meiragtx.com

Media:
Jason Braco, Ph.D.
LifeSci Communications
jbraco@lifescicomms.com

FAQ

When is Dr. Alexandria Forbes participating in investor conferences?

Dr. Alexandria Forbes, President and CEO of MeiraGTx Holdings plc (MGTX), will be participating in the 6th Annual Evercore ISI HealthCONx Conference on Tuesday, November 28, 2023, at 10:25 a.m. ET and the Piper Sandler 35th Annual Healthcare Conference on Thursday, November 30, 2023, at 9:00 a.m. ET.

Where can I watch the live webcast of the corporate presentations?

The live webcast of the corporate presentations will be available on the Investors page of MeiraGTx Holdings plc's website at www.investors.meiragtx.com.

How long will the replays of the corporate presentations be available?

Replays of the corporate presentations will be available for approximately 30 days following the presentation dates.